Antagonistic synergy: Process and paradox in the development of new agricultural antimicrobial regulations

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Antagonistic synergy : Process and paradox in the development of new agricultural antimicrobial regulations. / Dean, Wesley R.; Scott, H. Morgan.

I: Agriculture and Human Values, Bind 22, Nr. 4, 2005, s. 479-489.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Dean, WR & Scott, HM 2005, 'Antagonistic synergy: Process and paradox in the development of new agricultural antimicrobial regulations', Agriculture and Human Values, bind 22, nr. 4, s. 479-489. https://doi.org/10.1007/s10460-005-3403-y

APA

Dean, W. R., & Scott, H. M. (2005). Antagonistic synergy: Process and paradox in the development of new agricultural antimicrobial regulations. Agriculture and Human Values, 22(4), 479-489. https://doi.org/10.1007/s10460-005-3403-y

Vancouver

Dean WR, Scott HM. Antagonistic synergy: Process and paradox in the development of new agricultural antimicrobial regulations. Agriculture and Human Values. 2005;22(4):479-489. https://doi.org/10.1007/s10460-005-3403-y

Author

Dean, Wesley R. ; Scott, H. Morgan. / Antagonistic synergy : Process and paradox in the development of new agricultural antimicrobial regulations. I: Agriculture and Human Values. 2005 ; Bind 22, Nr. 4. s. 479-489.

Bibtex

@article{cccb28c9cff047fcba6ba43714d714e1,
title = "Antagonistic synergy: Process and paradox in the development of new agricultural antimicrobial regulations",
abstract = "There is currently great controversy over the contribution antimicrobial use in animal agriculture has made to antimicrobial resistance in pathogenic bacteria with negative consequences for human health. In light of this, the approval process for antimicrobials used in US animal agriculture, known as New Animal Drug Application or NADA, is currently being revised by the federal government. We explore the public deliberations over the development of these new policies focusing our attention on the interaction between pharmaceutical companies and the U.S. Food and Drug Administration. What appears to be an antagonistic public discourse is examined in terms of its ability to simultaneously legitimate the roles of the Food and Drug Administration as the official arbiter of policy on antimicrobial use in animal agriculture and as a protector of the public welfare, as well as the role of pharmaceutical companies as the producers of safe and effective products necessary for the protection of public well-being.",
keywords = "Antibiotics, Antimicrobials, Drug policy, Food and Drug Administration, Pharmaceutical companies, State theory",
author = "Dean, {Wesley R.} and Scott, {H. Morgan}",
year = "2005",
doi = "10.1007/s10460-005-3403-y",
language = "English",
volume = "22",
pages = "479--489",
journal = "Agriculture and Human Values",
issn = "0889-048X",
publisher = "Springer",
number = "4",

}

RIS

TY - JOUR

T1 - Antagonistic synergy

T2 - Process and paradox in the development of new agricultural antimicrobial regulations

AU - Dean, Wesley R.

AU - Scott, H. Morgan

PY - 2005

Y1 - 2005

N2 - There is currently great controversy over the contribution antimicrobial use in animal agriculture has made to antimicrobial resistance in pathogenic bacteria with negative consequences for human health. In light of this, the approval process for antimicrobials used in US animal agriculture, known as New Animal Drug Application or NADA, is currently being revised by the federal government. We explore the public deliberations over the development of these new policies focusing our attention on the interaction between pharmaceutical companies and the U.S. Food and Drug Administration. What appears to be an antagonistic public discourse is examined in terms of its ability to simultaneously legitimate the roles of the Food and Drug Administration as the official arbiter of policy on antimicrobial use in animal agriculture and as a protector of the public welfare, as well as the role of pharmaceutical companies as the producers of safe and effective products necessary for the protection of public well-being.

AB - There is currently great controversy over the contribution antimicrobial use in animal agriculture has made to antimicrobial resistance in pathogenic bacteria with negative consequences for human health. In light of this, the approval process for antimicrobials used in US animal agriculture, known as New Animal Drug Application or NADA, is currently being revised by the federal government. We explore the public deliberations over the development of these new policies focusing our attention on the interaction between pharmaceutical companies and the U.S. Food and Drug Administration. What appears to be an antagonistic public discourse is examined in terms of its ability to simultaneously legitimate the roles of the Food and Drug Administration as the official arbiter of policy on antimicrobial use in animal agriculture and as a protector of the public welfare, as well as the role of pharmaceutical companies as the producers of safe and effective products necessary for the protection of public well-being.

KW - Antibiotics

KW - Antimicrobials

KW - Drug policy

KW - Food and Drug Administration

KW - Pharmaceutical companies

KW - State theory

U2 - 10.1007/s10460-005-3403-y

DO - 10.1007/s10460-005-3403-y

M3 - Journal article

AN - SCOPUS:30044445900

VL - 22

SP - 479

EP - 489

JO - Agriculture and Human Values

JF - Agriculture and Human Values

SN - 0889-048X

IS - 4

ER -

ID: 255457669